Frequencies of CD33+CD11b+HLA-DR–CD14–CD66b+ and CD33+CD11b+HLA-DR–CD14+CD66b– Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19

Common clinical features of patients with Coronavirus disease-2019 (COVID-19) vary from fever, to acute severe respiratory distress syndrome. Several laboratory parameters are reported as indicators of COVID-19 severity. We hereby describe the possible novel severity biomarkers for COVID-19, CD11b+C...

Descripción completa

Detalles Bibliográficos
Autores principales: Alberca, Ricardo Wesley, Andrade, Milena Mary de Souza, Branco, Anna Cláudia Calvielli Castelo, Pietrobon, Anna Julia, Pereira, Nátalli Zanete, Fernandes, Iara Grigoletto, Oliveira, Luana de Mendonça, Teixeira, Franciane Mouradian Emidio, Beserra, Danielle Rosa, de Oliveira, Emily Araujo, Gozzi-Silva, Sarah Cristina, Ramos, Yasmim Álefe Leuzzi, de Brito, Cyro Alves, Arnone, Marcelo, Orfali, Raquel Leao, Aoki, Valeria, Duarte, Alberto Jose da Silva, Sato, Maria Notomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592395/
https://www.ncbi.nlm.nih.gov/pubmed/33178720
http://dx.doi.org/10.3389/fmed.2020.580677
Descripción
Sumario:Common clinical features of patients with Coronavirus disease-2019 (COVID-19) vary from fever, to acute severe respiratory distress syndrome. Several laboratory parameters are reported as indicators of COVID-19 severity. We hereby describe the possible novel severity biomarkers for COVID-19, CD11b+CD33+HLA-DR-CD14+ cells and CD11b+CD33+HLA-DR-CD66b+ cells.

Ejemplares similares